Related references
Note: Only part of the references are listed.Loss of Tid1/DNAJA3 Co-Chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence
Kuan-Yang Chen et al.
CANCERS (2021)
KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis
Shaoshan Yang et al.
ONCOGENE (2020)
Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53
Dandan Xu et al.
MOLECULAR CARCINOGENESIS (2019)
Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer
Yasuo Uno et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
Comparative oncology approach to drug repurposing in osteosarcoma
Alejandro Parrales et al.
PLOS ONE (2018)
The interplay between mutant p53 and the mevalonate pathway
Alejandro Parrales et al.
CELL DEATH AND DIFFERENTIATION (2018)
Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression
Xuetian Yue et al.
GENES & DEVELOPMENT (2017)
Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ
M. Escoll et al.
ONCOGENE (2017)
YAP/TAZ-CDC42 signaling regulates vascular tip cell migration
Masahide Sakabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation
Zuzanna Tracz-Gaszewska et al.
ONCOTARGET (2017)
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities
Swathi V. Iyer et al.
ONCOTARGET (2016)
Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2
Elvan Ergulen et al.
BIOCHEMICAL JOURNAL (2016)
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
Ge Zhou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway
Alejandro Parrales et al.
NATURE CELL BIOLOGY (2016)
Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
Hong-Lin He et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Mutant p53: One, no One, and One Hundred Thousand
Dawid Walerych et al.
FRONTIERS IN ONCOLOGY (2015)
Targeting Oncogenic Mutant p53 for Cancer Therapy
Alejandro Parrales et al.
FRONTIERS IN ONCOLOGY (2015)
DNAJC6 promotes hepatocellular carcinoma progression through induction of epithelial-mesenchymal transition
Tao Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
Chi-Yuan Chen et al.
CANCER RESEARCH (2013)
HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem-like Cells
Satoshi Nishizawa et al.
CANCER RESEARCH (2012)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
DNAJC25 is downregulated in hepatocellular carcinoma and is a novel tumor suppressor gene
Tingting Liu et al.
ONCOLOGY LETTERS (2012)
Molecular chaperones in protein folding and proteostasis
F. Ulrich Hartl et al.
NATURE (2011)
`The HSP70 chaperone machinery: J proteins as drivers of functional specificity
Harm H. Kampinga et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer
B. Y. Ahn et al.
ONCOGENE (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
Jenni K. Peltonen et al.
HEAD & NECK ONCOLOGY (2010)
Chaperones and protein folding in the archaea
Andrew T. Large et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma
Chi-Yuan Chen et al.
JOURNAL OF PATHOLOGY (2009)
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
Tamara Terzian et al.
GENES & DEVELOPMENT (2008)
Filopodia: molecular architecture and cellular functions
Pieta K. Mattila et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck
M. Luana Poeta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia
JS Chen et al.
BLOOD (2001)
Share Paper
